Product Information
EVEROLIMUS 0.25 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $2.1159 per EA under NDC 67877071831. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
.25 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877071831
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA214138On Market Since
11/27/2021
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 0.25 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 33.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1159 per EA |
|---|---|
| All-time high | $3.1849 (May 15, 2024) |
| All-time low | $2.0574 (Jul 23, 2025) |
| 52-week high | $2.3327 |
| 52-week low | $2.0574 |
| Median price | $2.1675 |
| Average price | $2.2552 |
| Largest weekly change | -17.7% (May 22, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EVEROLIMUS 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 0.25 MG TABLET, manufactured by Ascend Laboratories, LLC, is $2.1159 per EA (NDC 67877071831), effective Jun 24, 2026.
How has the price of EVEROLIMUS 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 0.25 MG TABLET has declined 33.6%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 0.25 MG TABLET?
Since Apr 17, 2024, the NADAC for EVEROLIMUS 0.25 MG TABLET has ranged from a low of $2.0574 (Jul 23, 2025) to a high of $3.1849 (May 15, 2024), with a median of $2.1675 per EA.
Are there cheaper alternatives to EVEROLIMUS 0.25 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as EVEROLIMUS 0.25 MG TABLET, but none are currently priced below it.
Who manufactures EVEROLIMUS 0.25 MG TABLET?
EVEROLIMUS 0.25 MG TABLET (NDC 67877071831) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification